| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8214970 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 9 Pages |
Abstract
Liver volume reductions were observed after 7Â days of sorafenib, prior to RT, most marked in patients with focal liver tumors, suggesting an effect of sorafenib on normal liver. Careful assessment of potential liver volume changes immediately prior to SBRT may be necessary in patients in sorafenib or other targeted therapies.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Anand MD, Jennifer J. MSc, MD, James D. MD, Rob MSc, MD, Rebecca MSc, MBChB, Zahra MSc, MBBS, John MD, Catherine PhD, Kristy K. PhD, Laura A. MD,